secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2026-05-13T20:12:25+00:00
Accession:  0001437749-26-016726
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical Q1 revenue $0.5M, up 69% YoY; net loss $3.5M
------------------------------------------------------------

- Net revenue of $0.5M from QUELIMMUNE sales, vs $0.3M in Q1 2025.
- Net loss $3.5M ($0.90/share) vs $3.8M ($4.38/share) a year ago.
- Cash $9.3M at March 31, down from $12.0M at Dec 31, 2025.
- NEUTRALIZE-AKI trial enrolled 198 of 339 patients; PMA submission efforts initiated.
- Added 7 children’s hospitals, now 17 total, targeting 15 more in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000143774926016726/0001437749-26-016726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000143774926016726/icu20260408_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-016726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer